Nurix Therapeutics, Inc. · NASDAQ:NRIX

Hansen Gwenn sold 4,111 Nurix Therapeutics, Inc. shares (Form 4)

Traded Aug 4, 2026 · Filed Aug 5, 2026

On Aug 4, 2026, Hansen Gwenn (Chief Scientific Officer) sold 4,111 Nurix Therapeutics, Inc. shares at an average US$24.36 for US$100K under a trading plan, leaving 117,227 shares. Filed Aug 5, 2026 (Form 4).

Sold
4,111 shares
Price
US$24.36 average (US$23.87 to US$24.64)
Value
US$100K
Holding after
117,227 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Aug 4, 2026Common StockSale1,500US$23.87119,838Direct
Aug 4, 2026Common StockSale2,611US$24.64117,227Direct

Source

View original at SEC

Related